România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ge healthcare buchler gmbh & co. kg - germania - selenium (75se) acid tauroselcolic - caps. - 370kbq - ficat si sistem reticuloendotelial alte radiofarmaceutice de diagnosticare a sistemului hepatic

Uniunea Europeană - română - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - respingerea grefei - imunosupresoare - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

novartis pharma ag - cyclosporinum - capsule moi - 100 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

novartis pharma ag - cyclosporinum - capsule moi - 25 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

novartis pharma ag - cyclosporinum - capsule moi - 50 mg

Uniunea Europeană - română - EMA (European Medicines Agency)

amgen europe bv - apremilast - arthritis, psoriatic; psoriasis - imunosupresoare - psoriazică arthritisotezla, singur sau în combinație cu boala modificarea medicamente antireumatice (dmard), este indicat pentru tratamentul artritei psoriazice active (psa) la pacienții adulți care au avut un răspuns inadecvat sau care au intoleranță la o prealabilă terapie dmard. psoriasisotezla este indicat pentru tratamentul formelor moderate până la severe de psoriazis în plăci la pacienții adulți care nu au răspuns sau care au o contraindicație sau intoleranță la alte tratamente sistemice incluzând ciclosporina, metotrexatul sau psoralen și ultraviolete-o lumină (puva).

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

krka d.d., novo mesto - ciprofloxacinum - comprimate filmate - 750 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

krka d.d., novo mesto - ciprofloxacinum - comprimate filmate - 250 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

krka d.d., novo mesto - ciprofloxacinum - comprimate filmate - 500 mg

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zentiva k.s. - metoclopramidum - comprimate filmate - 200 mg